Toxicology
GLP and Non-GLP Toxicology Programs Built for Speed, Clarity, and Confidence
At Envol Biomedical, we deliver toxicology studies that are fast, flexible, and fit for regulatory submission. Whether you're in early discovery or approaching IND-enabling milestones, our team provides robust, high-integrity toxicology programs rooted in nonhuman primate (NHP) models, regulatory compliance, and a relentless focus on sponsor outcomes.
Our toxicologists, study directors, and scientific team work side by side with clients to generate data that is clear, timely, and defensible—supported by full-service capabilities and vertically integrated resources.

Our Approach to Toxicology
Toxicology is more than a regulatory checkbox. At Envol, it’s a science-driven discipline that integrates:
- Rigorous study design and execution
- High quality biological assessments
- Cutting-edge analytics and reporting
- True responsiveness to shifting sponsor needs
We offer both GLP and non-GLP toxicology services, with a focus on speed to report, transparent communication, and scientific flexibility
GLP Compliance and Regulatory Readiness
We specialize in supporting IND-enabling toxicology with all necessary regulatory features:
- GLP-compliant facility and processes
- SEND-ready data output
- LIMS enabled
- Real-time reporting via Resero
- Qualified study directors and toxicologists
Our team understands the criticality of timelines and the consequences of delays. That’s why we prioritize precision, proactive scheduling, and transparent updates throughout every study.
Specialty Endpoints and Cross-Functional Integration
- Neurological
- Respiratory
- Cardiovascular
- Gastrointestinal
- And more
- In-study sample prep and coordination
- Pathology reporting integration
- Study director oversight across clinical, pathology, and reporting phases
- Real-time data transformation
- Rapid turnaround on preliminary and final reports
- Automated SEND datasets
- Visual summaries for internal and external stakeholder review
Why Sponsors Choose Envol for Toxicology
- IND-enabling study expertise
- GLP, SEND, and LIMS-compliant workflows
- Surgical dosing and functional endpoints
- Resero-powered reporting & modeling
- Rapid start-up and responsive communication
Whether you’re initiating a toxicology screen or preparing your final IND package, Envol delivers the scientific credibility, technical capability, and service-first approach you need to move forward—on time and with confidence.
Study Types and Toxicology Capabilities
- Repeat dose toxicology studies
- Investigational and discovery-stage tox
- Safety assessments across diverse administration routes
- Studies incorporating CNS, ocular, respiratory, and cardiovascular endpoints
Supporting Capabilities for Toxicology
- Surgical Capabilities: Specialized dosing access (e.g., CNS, intrathecal, intranasal), serial sampling, implant placement
- Core Laboratory Services:
- Clinical pathology (hematology, chemistry, coagulation, urinalysis)
- Immunology (cytokines, flow cytometry, ELISA)
- Ligand-binding assays
- ADA, PCR, ddPCR

Recent Blogs
The Evolution of Primate Supply Chains: Envol Biomedical’s Jake McDonald to Present at ACT 2025
As one of the nation’s leading GLP toxicology partners, Envol Biomedical is proud to be...Advancing CNS Drug Development: Envol Biomedical to Debut First-in-Kind NHP COFM Capabilities at ACT 2025
As one of the nation’s leading GLP toxicology partners and the largest provider of NHP...The Ripple Effects of Uncertainty Around FDA Changes: Envol Biomedical and White Oak Regulatory Tox Present at ACT 2025
Few years in recent memory have tested the clarity and consistency of the FDA’s regulatory...Let's Plan Your Toxicology Program
Need to hit a regulatory milestone? Evaluating a new route of administration?

